Cocktail-substrate assay system for mechanism-based inhibition of CYP2C9, CYP2D6, and CYP3A using human liver microsomes at an early stage of drug development

By Mori K.   Hashimoto H.   Takatsu H.   Tsuda-Tsukimoto M.   Kume T.  

Xenobiotica, Vol. 39, Iss. 6, 2009-06 ,pp. : 415-422

Informa Healthcare

Access to resources Recommend Favorite

Mechanism-based inhibition of CYP1A2 by antofloxacin, an 8-NH2 derivative of levofloxacin in rats

By Zhu Q.   Liao J.   Xie L.   Wang G. J.   Liu X. D.  

Xenobiotica, Vol. 39, Iss. 4, 2009-04 ,pp. : 293-301

Informa Healthcare

Access to resources Recommend Favorite

CYP2D6-mediated catalysis of tamoxifen aromatic hydroxylation with an NIH shift: similar hydroxylation mechanism in chicken, rat and human liver microsomes

By Hu Y.   Dehal S. S.   Hynd G.   Jones G. B.   Kupfer D.  

Xenobiotica, Vol. 33, Iss. 2, 2003-02 ,pp. : 141-151

Informa Healthcare

Access to resources Recommend Favorite

CYP2D6-mediated catalysis of tamoxifen aromatic hydroxylation with an NIH shift: similar hydroxylation mechanism in chicken, rat and human liver microsomes, 33, pp. 141-151.

By Hu Y.   Dehal S.S.   Hynd G.   Jones G.B.   Kupfer D.  

Xenobiotica, Vol. 33, Iss. 8, 2003-08 ,pp. : 885-885

Informa Healthcare

Access to resources Recommend Favorite

Metabolite-intermediate complexation and inhibition of microsomal CYP3A in rat liver by diltiazem

By Trieu L.   Murray M.  

Xenobiotica, Vol. 30, Iss. 2, 2000-02 ,pp. : 131-140

Informa Healthcare

Access to resources Recommend Favorite